#Australia #LabConnect #Clinical Trials #Port Melbourne #Australian Clinical Labs

LabConnect and Australian Clinical Labs: A Game-Changing Partnership

LabConnect and Australian Clinical Labs' (ACL) Specialised Trials have proudly announced the formation of a strategic partnership aimed at enhancing support for clinical trials, specifically in Australia and the broader Asia-Pacific region. This exclusive, multi-year agreement will leverage the complementary strengths of both organizations, addressing the rising demand for clinical trial support services among pharmaceutical, biotechnology, and clinical research organizations in the region.

ACL Specialised Trials stands out as a major player in the clinical trial laboratory market in Australia. It manages a wide array of clinical studies, ranging from phase 1 to phase 4 clinical trials. With an extensive network of laboratories throughout Australia, ACL Specialised Trials is distinguished by its capability to provide comprehensive pathology solutions and a vast array of central lab services for both national and multi-center clinical trials.

According to Melinda McGrath, CEO of ACL Group, "This long-term partnership will facilitate international clients’ access to Australian patients and bring significant international trials to this part of the world. Ultimately, this will lead to groundbreaking medical advancements that can save lives and improve patient outcomes." McGrath further emphasized the importance of the partnership in strengthening ACL's position in a rapidly growing $8 billion market, expressing pride in showcasing the organization's expertise and the talented team on a global platform.

LabConnect, recognized as the world's most agile central laboratory solutions partner, aims to capitalize on ACL's extensive test menu combined with a full suite of services to support the region. This includes local kit creation, biospecimen management, project and data management, and logistical support. Catherine Osborne, General Manager of APAC, oversees the growing LabConnect operations and businesses in the region.

As the primary laboratory service provider for LabConnect in Australia and the APAC region, ACL Specialised Trials is poised to enhance LabConnect's services with its specialist laboratory capabilities and project team located in Port Melbourne, Victoria. This facility will act as a central operational hub for the region.

Wes Wheeler, CEO of LabConnect, highlighted the increasing focus of their clients on integrating APAC research centers into their clinical development plans. He commented, "Our partnership with ACL Specialised Trials provides us with a strong platform to deliver our extensive, industry-leading suite of central laboratory services across the region."

About ACL Specialised Trials

ACL Specialised Trials, a subsidiary of Australian Clinical Labs, is dedicated to enhancing patients' lives through medical excellence, advanced market-leading technology, and a team of highly-skilled professionals. The organization offers specialized pathology services for clinical trials spanning phases I to IV, ensuring that clients receive top-quality solutions. Their state-of-the-art facilities, combined with years of clinical and commercial trial experience, ensure a seamless transition from initial consultation to final delivery.

About LabConnect

LabConnect is renowned for providing customizable, orchestrated, and scalable technology-based support services for clinical trials of all sizes and complexities. Boasting over 20 years of experience and having contributed to more than 1,900 clinical studies across 93 countries, LabConnect has established itself as a trusted partner for biotechnology, pharmaceutical, and clinical research organizations. With modern operations and strategic alliances with leading laboratories worldwide, LabConnect is uniquely placed to provide access to the latest innovations and automation.

Their comprehensive central laboratory service offerings encompass custom laboratory kits, advanced sample tracking, integrated logistics, standardized global sample processing, and a leading test menu with over 10,200 validated assays. LabConnect’s scientific experts facilitate preclinical and clinical studies through project management, bioanalytical management, biomarker strategy, and logistics. The organization excels in data management by integrating complex data sets from various sources into a cohesive dataset ready for reporting.

As LabConnect and ACL embark on this partnership, it promises to significantly enhance the support and efficiency of clinical trials in the region, ultimately benefiting patients and expanding access to innovative treatments.